Jenburkt Pharmaceuticals

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue36.0336.4630.2239.3937.01
Expenses28.2728.3822.7829.8529.16
EBITDA8.448.758.0010.208.54
EBIT7.868.167.509.617.91
Profit Before Tax7.758.077.439.547.84
Net Profit5.436.355.377.325.40
Financial Ratios
Operating Profit Margin24.41%24.86%27.42%26.64%23.95%
Net Profit Margin15.71%18.04%18.40%19.12%15.14%
Earning Per Share (Diluted)11.8413.9212.1716.5912.25
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ